Andean highlanders adapt to thin air through epigenetic gene tuning, revealing a flexible, long-term path to altitude survival.
Celcuity has successfully transitioned from a speculative biotechnology company to a pre-commercial firm with a de-risked ...
Plexiform neurofibromas (PNF) are benign, often infiltrative tumours of the peripheral nerve sheath classically linked to ...
An aggressive breast cancer lacking common drug targets, triple-negative breast cancer may be countered by oridonin, a ...
Early data suggest retatrutide may drive faster and greater weight loss, which fuels interest in looksmaxxing spaces.
THIS YEAR, the highly anticipated European Society for Medical Oncology (ESMO) Congress 2025 was held in Berlin, ...
Background Chronic stress is a known risk factor for cancer metastasis. However, the underlying mechanisms, particularly ...
MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback